Wettan Keeley M. Cain

CIK: 0002110603

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (36.4%)

Derivative conversions

Awards (A)3 (27.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (36.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GILD

GILEAD SCIENCES, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

GILD
GILEAD SCIENCES, INC.
Sep 10, 2026
Exercise(M)
Direct
590 shares-
GILD
GILEAD SCIENCES, INC.
Sep 10, 2026
Tax Payment(F)
Direct
285 shares at avg. $144.81$41K
GILD
GILEAD SCIENCES, INC.
Aug 10, 2026
Tax Payment(F)
Direct
2.9K shares at avg. $133.06$387K
GILD
GILEAD SCIENCES, INC.
Aug 10, 2026
Exercise(M)
Direct
6K shares-
GILD
GILEAD SCIENCES, INC.
Jun 10, 2026
Exercise(M)
Direct
589 shares-
GILD
GILEAD SCIENCES, INC.
Jun 10, 2026
Tax Payment(F)
Direct
283 shares at avg. $121.48$34K
GILD
GILEAD SCIENCES, INC.
Mar 10, 2026
Award(A)
Non-qualified Stock Option (Right to Buy)
Direct
18.9K shares-
GILD
GILEAD SCIENCES, INC.
Mar 10, 2026
Exercise(M)
Direct
1.2K shares-
GILD
GILEAD SCIENCES, INC.
Mar 10, 2026
Tax Payment(F)
Direct
606 shares at avg. $148.56$90K
GILD
GILEAD SCIENCES, INC.
Mar 10, 2026
Award(A)
Restricted Stock Unit
Direct
5.1K shares-
GILD
GILEAD SCIENCES, INC.
Feb 27, 2026
Award(A)
Direct
470 shares-

		Type	Shares	Price		Ownership
Sep 10, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	590	-	$0	Direct
Sep 10, 2026	GILD GILEAD SCIENCES, INC.	Tax Payment(F)	285	$144.81	$41,271	Direct
Aug 10, 2026	GILD GILEAD SCIENCES, INC.	Tax Payment(F)	2,908	$133.06	$386,938	Direct
Aug 10, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	6,002	-	$0	Direct
Jun 10, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	589	-	$0	Direct
Jun 10, 2026	GILD GILEAD SCIENCES, INC.	Tax Payment(F)	283	$121.48	$34,379	Direct
Mar 10, 2026	GILD GILEAD SCIENCES, INC.	Award(A) Non-qualified Stock Option (Right to Buy)	18,885	-	-	Direct
Mar 10, 2026	GILD GILEAD SCIENCES, INC.	Exercise(M)	1,246	-	$0	Direct
Mar 10, 2026	GILD GILEAD SCIENCES, INC.	Tax Payment(F)	606	$148.56	$90,027	Direct
Mar 10, 2026	GILD GILEAD SCIENCES, INC.	Award(A) Restricted Stock Unit	5,050	-	-	Direct
Feb 27, 2026	GILD GILEAD SCIENCES, INC.	Award(A)	470	-	$0	Direct

1-11 of 11 transactions

About Cain Wettan Keeley M

Cain Wettan Keeley M (SEC CIK 0002110603) files insider reports with the SEC as EVP Gen Counsel, Legal & Comp of GILEAD SCIENCES, INC. (GILD).

Signal8 holds 6 ownership filings by Cain Wettan Keeley M (1 Form 3, 5 Form 4), filed between Feb 12, 2026 and Sep 11, 2026. Those filings report 11 transactions, from Feb 27, 2026 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cain Wettan Keeley M's filings is in FOSTER CITY, CA.

Recent filings by Cain Wettan Keeley M

Sep 10, 2026: Option exercise of GILD shares (Form 4, code M).
Sep 10, 2026: Tax withholding of GILD shares (Form 4, code F).
Aug 10, 2026: Tax withholding of GILD shares (Form 4, code F).
Aug 10, 2026: Option exercise of GILD shares (Form 4, code M).
Jun 10, 2026: Option exercise of GILD shares (Form 4, code M).

Other insiders filing for GILEAD SCIENCES, INC. (GILD)

O'Day Daniel Patrick, Chairman & CEO
Dickinson Andrew D, Chief Financial Officer
Mercier Johanna, Chief Comm & Corp Aff Officer
Burkhart Erin, SVP, Controllership
Berger Dietmar, Chief Medical Officer
WELTERS ANTHONY, Director

How to read Form 4 transaction codes